Editas medicine stock price.

They need the money for the next leg of the journey, and their stock price is as good as it'll likely get until more data comes out. Take Editas Medicine (EDIT 2.28%) as an example. On June 9, it ...On Wednesday, Editas Medicine Inc [NASDAQ: EDIT] rose 3.76% to $8.84. The stock’s lowest price that day was $8.50, but it reached a high of $9.15 in the same session. During the last five days, there has been a surge of approximately 5.24%. Over the course of the year, Editas Medicine Inc shares have dropped approximately -0.34%.Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.Aug 23, 2023 · The average price targets for Editas Medicine and Intellia Therapeutics are $13.18 and $83.75, respectively, according to Yahoo! Finance. That implies an upside of about 54% for the former and 119 ... If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

Editas Medicine stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Why Editas Medicine Stock Is Soaring Today Motley Fool - Fri Sep 29, 10:21AM CDT . Investors are cheering a big analyst upgrade for the gene-editing stock. VRTX: 351.16 (-1.03%)

Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 8.55% so far this month. During the month of April, Editas Medicine Inc’s stock price has reached a high of $7.21 and a low of $6.45. Over the last year, Editas Medicine Inc has hit prices as high as $20.04 and as low as $6.70. Year to date, Editas ...On June 15, Editas Medicine ( EDIT 3.66%) saw its shares collapse by 15% after announcing it would be issuing new stock to raise approximately $125 million. The biotech will almost certainly use ...

Nov 24, 2023 · Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Price of Stock Editas Medicine (EDIT) Today.Get the latest Editas Medicine, Inc. (EDIT) stock news and headlines to help you in your trading and investing decisions.Feb 2, 2023 · Why Editas Medicine Stock Charged Higher in January. By George Budwell – Feb 2, 2023 at 11:33AM Key Points. ... Current Price. $10.58. Price as of November 24, 2023, 1:00 p.m. ET. Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.

10.68 BATS BZX Real-Time Price As of 3:23pm ET +0.15 / +1.42% Today’s Change 6.08 Today ||| 52-Week Range 11.93 +20.41% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders...

Nov 20, 2023 · The average price target on the stock implies a 67% gain over the next 12 months. ... The past month has been a great one for Editas Medicine (EDIT 0.86%), but the stock is still down about 89% ...

Editas Medicine is a high-risk stock with the potential of a big reward. ... Current Price. $10.88. Price as of November 29, 2023, 11:23 a.m. ET.View the real-time EDIT price chart on Robinhood, Editas Medicine stock live quote and latest news. You can buy and sell Editas Medicine (EDIT) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.View Editas Medicine, Inc EDIT investment & stock information. Get the latest Editas Medicine, Inc EDIT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.The Motley Fool has positions in and recommends Beam Therapeutics, CRISPR Therapeutics, Caribou Biosciences, Editas Medicine, Intellia Therapeutics, and Vertex …It's been a tough year for Editas Medicine (EDIT-0.26%) so far. As of the market close on Monday, the stock was down 42%. But shares of Editas were rebounding by 8.2% as of 11:25 a.m. EST on ...Jan 10, 2023 · In the last 3 months, 18 analysts have offered 12-month price targets for Editas Medicine. The company has an average price target of $19.17 with a high of $43.00 and a low of $6.00.

The stock option provides for the purchase of up to 123,350 shares of Editas Medicine common stock at a price of $8.00 per share, the closing price per share of Editas Medicine common stock as ...Dec 1, 2023 · With Editas Medicine stock trading at $6.26 per share, the total value of Editas Medicine stock (market capitalization) is $511.02M. Editas Medicine stock was originally listed at a price of $18.20 in Feb 3, 2016. Gene editing stocks rallied Thursday as Wall Street took notice of the underperforming subsector issuing a series of bullish views despite recent selloff. Read more here.Editas Medicine Inc stock price live 10.42, this page displays NASDAQ EDIT stock exchange data. View the EDIT premarket stock price ahead of the market session or assess the after hours quote.The Editas Medicine stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.Editas Medicine Announces Pricing of Offering of Common Stock 06-15 - 2 views Editas Medicine Announces Positive Initial EDIT-301 Safety and Efficacy Data from the First Four Patients Treated in the RUBY Trial and the First Patient Treated in the EdiTHAL Trial EDIT-301 was well-tolerated and demonstrated a safety profile consi 06-09 - 1 view

Get the latest Editas Medicine, Inc. (EDIT) stock news and headlines to help you in your trading and investing decisions.Get a real-time Editas Medicine, Inc. (EDIT) stock price quote with breaking news, financials, statistics, charts and more.

What happened. Shares of Editas Medicine ( EDIT 2.28%) were up 13.9% this week as of the market close on Thursday. Most of this big gain came after a key announcement from the company on Wednesday ...Get Editas Medicine Inc (EDIT.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... Price To Sales (TTM) 26.58. Price To Book ...Dec 1, 2023 · 12 Wall Street analysts have issued 1-year price objectives for Editas Medicine's stock. Their EDIT share price targets range from $7.00 to $30.00. On average, they expect the company's share price to reach $13.92 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price. Historical daily share price chart and data for Editas Medicine since 2016 adjusted for splits and dividends. The latest closing stock price for Editas Medicine as of November 20, …See the latest Editas Medicine Inc stock price (EDIT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.

Editas Medicine stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics Motley Fool - Mon Oct 2, 9:00AM CDT . The better of the pair should be able to beat Bluebird Bio. EDIT: 10.77 (+2.28%) CRSP: 68.65 (+2.88%) Why Editas …

On June 15, Editas Medicine ( EDIT 3.66%) saw its shares collapse by 15% after announcing it would be issuing new stock to raise approximately $125 million. The biotech will almost certainly use ...

Editas Medicine's cash burn of US$181m is about 36% of its US$503m market capitalisation. That's fairly notable cash burn, so if the company had to sell shares to cover the cost of another year's ...Our information suggests that Editas Medicine, Inc. insiders own under 1% of the company. It appears that the board holds about US$2.6m worth of stock. This compares to a market capitalization of ...Dec 1, 2023 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Editas Medicine stock is Hold based on the current 1 sell rating, 6 hold ratings and 5 buy ratings for EDIT. The average twelve-month price prediction for Editas Medicine is $13.92 with a high price target of $30.00 and a low price target of $7.00. Learn ... Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Editas Medicine Inc’s Stock Price as of Market Close. As of March 13, 2023, 4:00 PM CST, Editas Medicine Inc’s stock price was $8.43. Editas Medicine Inc is up 7.66% from its previous closing price of $7.83. During the last market session, Editas Medicine Inc’s stock traded between $7.48 and $8.15. Currently, there are 68.79 million …A high-level overview of Editas Medicine, Inc. (EDIT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.According to the issued ratings of 12 analysts in the last year, the consensus rating for Editas Medicine stock is Hold based on the current 1 sell rating, 6 hold ratings and 5 buy ratings for EDIT. The average twelve-month price prediction for Editas Medicine is $13.92 with a high price target of $30.00 and a low price target of $7.00. Learn ...Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.11.34%. Get the latest Editas Medicine Inc (EDIT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Editas Medicine, Inc. Price and Consensus. ... Editas Medicine, Inc. (EDIT) : Free Stock Analysis Report CRISPR Therapeutics AG (CRSP) : Free Stock Analysis ReportThe flu season can strike at any time, leaving us feeling unwell with symptoms like fever, cough, sore throat, and fatigue. While getting a flu shot is the best prevention, sometimes the flu sneaks through. That’s when having the right over...

Shares of clinical-stage biotech Editas Medicine ( EDIT 3.66%) rose as much as 14% on Monday, lifted by a trend over the past couple of days favoring gene-editing stocks. Editas stock also ...The decrease was driven by reduced headcount related expense, including stock compensation, and reduced legal costs. Upcoming Events Editas Medicine plans to participate in the following scientific and medical conference: American Society of Hematology (ASH) ... Chardan Cuts Price Target on Editas Medicine to $19 From $22, …The Editas Medicine, Inc stock price fell by -0.754% on the last day (Thursday, 30th Nov 2023) from $10.61 to $10.53.During the last trading day the stock fluctuated 5.51% from a day low at $10.44 to a day high of $11.01.The price has risen in 6 of the last 10 days and is up by 19.12% over the past 2 weeks. Volume has increased on …Instagram:https://instagram. nyse ttitax yield checksgood tax software for self employedhome loan 500 credit score Editas Medicine (EDIT) stock price prediction is 21.694681385149 USD. The Editas Medicine stock forecast is 21.694681385149 USD for 2024 November 30, ... vinfast stocbest crypto tracker Get the latest Editas Medicine, Inc. (EDIT) stock news and headlines to help you in your trading and investing decisions. what was the highest price of gold Editas (EDIT) Q3 Earnings & Revenues Beat, Pipeline in Focus. Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.CAMBRIDGE, Mass. and SAN DIEGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it has entered into a definitive agreement with Shoreline Biosciences (Shoreline) for Shoreline to license Editas Medicine’s proprietary SLEEK (SeLection by …